In Brief
The role of TGF-b in supporting differentiated Treg cells remains unaddressed. Konkel et al. demonstrate vital roles for TGF-b signals in reinforcing specific Treg cell functions. TGF-b signals limit Treg suppression of Th1-responses but are key for Treg cell function in the colon, revealing unrecognized roles for TGF-b in controlling Treg cell activity in specific tissues.
SUMMARY
Regulatory T cells (Treg cells) perform suppressive functions in disparate tissue environments and against many inflammatory insults, yet the tissue-enriched factor(s) that influence Treg cell phenotype and function remain largely unknown. We have shown a vital role for transforming growth factor-b (TGF-b) signals in safe-guarding specific Treg cell functions. TGF-b signals were dispensable for steady-state Treg cell homeostasis and for Treg cell suppression of T cell proliferation and T helper-1 (Th1) cell differentiation. However, Treg cells require TGF-b signals to appropriately dampen Th17 cells and regulate responses in the gastrointestinal tract. TGF-b signaling maintains CD103 expression, promotes expression of the colon-specific trafficking molecule GPR15, and inhibits expression of GPR174, a receptor for lysophosphatidylserine, on Treg cells, collectively supporting the accumulation and retention of Treg cells in the colon and control of colitogenic responses. Thus, we reveal an unrecognized function for TGF-b signaling as an upstream factor controlling Treg cell activity in specific tissue environments.
INTRODUCTION
Regulatory T cells (Treg cells) that express the transcription factor Foxp3 play a central role in maintaining immune homeostasis, suppressing autoimmunity, and regulating immunity to infections and tumors (Chen and Wahl, 2003; Nishikawa and Sakaguchi, 2014) . Exhibiting functional and phenotypic heterogeneity, Treg cells mediate their regulatory actions in different tissues and in response to many stimuli. Responding to environmental cues, Treg cells acquire distinct characteristics, tailoring them to the response to be regulated (Campbell and Koch, 2011) . In this regard, Treg cell expression of the transcription factor T-bet is required for suppression of T helper-1 (Th1) responses (Koch et al., 2009 ), interferon regulatory factor-4 (IRF4) for suppression of T helper-2 (Th2) responses (Zheng et al., 2009 ), STAT3 for suppression of T helper-17 (Th17) responses , and GATA-3, important for control of effector T cells (Wohlfert et al., 2011) . However, the upstream stimuli and signals enforcing these suppressive Treg cell programs are poorly understood.
Tailoring of Treg cell functionality occurs not only at the level of the targeted immune response, but also by the tissue site in which these cells are to function; for example, specialized Treg cells operate in adipose tissue (Cipolletta et al., 2012) and muscle (Burzyn et al., 2013) . In addition, interleukin-10 (IL-10) production by Treg cells is vital to control gastrointestinal (GI) inflammation (Rubtsov et al., 2008) . To appropriately function in specific tissue locations, Treg cells must be recruited to and retained at the tissue site, as well as be able to persist in that environment. The factors supporting Treg cells in tissues are incompletely understood, but better understanding of these factors would promote development of strategies to reinforce Treg cell function in specific tissues during aberrant inflammation.
By generating transgenic mice in which TGF-b receptor I (TGFbRI) was specifically deleted in Foxp3 + Treg cells (Tgfbr1 f/f Foxp3-cre + ), we show that lack of TGF-b signals to Treg cells increased their suppression of Th1 cells but resulted in an inability to control Th17 cells. Moreover, we found that deletion of Tgfbr1 on Treg cells led to a profound defect in recruitment and retention of Treg cells in the GI tract, resulting in an inability to regulate inflammation at this site. Our data indicate that TGF-b signals are vital for ensuring appropriate expression of integrins and G-proteincoupled receptors that support accumulation of Treg cells in the colon. Combined, our data demonstrate an essential role for TGF-b signals in Treg cell suppression of specific T-helper subsets and to control tissue-specific immune responses. Figure S1E ).
RESULTS

Increased Th17 Cells in the GI
However, when we aged Tgfbr1
Foxp3-cre + mice to one year, we noted aberrant immune functionality. Loss of immune control occurred within the GI tract ( Figure 1E ) and skin ( Figure S2A ), where we saw a specific increase in IL-17 production by CD4 Increased Th17 Cells in the Central Nervous System during EAE Our data suggest that TGF-bR1 deletion on Treg cells promotes selective immune dysfunction resulting in enhanced GI IL-17 production with age. To ascertain whether this was a GI specific defect or resulted from the chronic inflammatory stimuli experienced in the GI tract, we induced experimental autoimmune encephalomyelitis (EAE) in Tgfbr1 f/f Foxp3-cre + mice. IL-17 production is vital for EAE pathology (Langrish et al., 2005) , but the inflammation is characterized by presence of Th1 and Th17 cells in the central nervous system (CNS) (O'Connor et al., 2008) .
Tgfbr1
f/f Foxp3-cre + mice exhibited a similar severity of disease compared to controls (Figure 2A) . Analysis of the CNS infiltrates showed the total numbers of the immune cells were similar between all mice, yet there were differences in the profiles of CNS resident cells. Figures 3A and 3B ). When the same suppression assay was performed in both the absence and presence of Th1-favoring cytokines (IL-12+IFN-g), Tgfbr1
À/À Treg cells were also better at suppressing IFN-g production by effector T cells ( Figures 3C-3E ). Indeed, compared to controls, Tgfbr1 À/À Treg cells were approximately 5%-10% better at suppressing CD4 + T cell IFN-g production ( Figure 3E ). In contrast to the enhanced suppression of IFN-g, in non-polarizing cultures, Tgfbr1 À/À Treg cells were less well able to suppress IL-17 production. Tgfbr1 À/À Treg cells had a reduced capacity to suppress IL-17 production by approximately 10% ( Figure 3E ). These alterations in suppressive capacity were not merely a result of better suppression of IFN-g causing greater IL-17 production, as addition of anti-IFN-g to cultures did not alter the suppressive capacity of Tgfbr1 À/À Treg cells ( Figures S3A-S3C ), nor was altered suppressive capacity due to altered Foxp3 expression ( Figure S3D ). We next addressed whether decreased suppression of IL-17 production would occur in Th17 differentiation conditions. In this setting, again, IL-17 production by effector CD4 + T cells was higher in cultures with Tgfbr1 À/À Treg cells compared to controls ( Figure 3F ). However, unlike in non-polarizing culture conditions, in IL-17 polarizing conditions, increased IL-17 production was not due to the reduced ability of Tgfbr1 À/À Treg cells to suppress IL-17 production. Instead, when IL-6 was added to the assays, the presence of the Tgfbr1 À/À Treg cell itself promoted greater production of IL-17 from co-cultured CD4 + T cells ( Figure 3G ). This enhancement of IL-17 production was not due to elevated production of TGF-b1 or expression of the high-affinity IL-2 receptor (CD25) by Tgfbr1 À/À Treg cells (Figure S3E) , mechanisms previously shown to support Treg cell enhancement of Th17 polarization Gutcher (F) Figure S1 and S2.
et al., 2011). Altered suppressive capacity was also not due to alterations in pro-inflammatory cytokine production by Treg cells ( Figure S3F ). Completing the comparison of Treg cell suppressive capabilities, we show that the ability of Tgfbr1 À/À Treg cells to suppress Th2 responses was the same as controls both in vitro ( Figure 3E ) and in vivo (Figures S3G and S3H) . Combined, these data indicate that Tgfbr1 À/À Treg cells exhibit an enhanced ability to suppress Th1 cells, yet could not limit IL-17 production from CD4 + T cells, as well as control Treg cells. In the presence of IL-6, this altered capacity to regulate IL-17 production was due to Tgfbr1 À/À Treg cells promoting enhanced IL-17 production ( Figure 3G ).
TGF-bRI-Deficient Treg Cells Exhibit Elevated T-bet Expression
We next investigated the underlying mechanisms by which Tgfbr1 À/À Treg cells mediated enhanced suppression of Th1 cells. 5F ), an integrin aiding retention of cells in the GI tract (Casey et al., 2012; El-Asady et al., 2005) . Loss of CD103 expression on Treg cells was also seen in the spleen of colitic mice, despite similar numbers of splenic Treg cells ( Figures S5D and S5E) . We further examined the Tgfbr1 f/f Foxp3-cre + mice in which the Treg cell frequency was unaltered ( Figures 1B and 1F ). Despite similar frequencies of total Treg cells, the percent of these expressing CD103 was dramatically reduced in all tissue sites and lymphoid organs examined ( Figures S5F and S5G ). This included TGF-bRI-deficient Treg cells in the CNS during EAE ( Figure S5H ) and in in vitro suppression assays ( Figure S5I ). Combined, these data clearly indicate that TGF-b signals are vital for Treg cell expression of CD103. Loss of TGF-b signals to Treg cells also resulted in altered expression of GPR174, a G-protein-coupled receptor for lysophosphatidylserine (LysoPS). Tgfbr1 À/À Treg cells had elevated expression of GPR174 ( Figure 5G ), downstream signals from which have been shown to limit colon Treg cell accumulation (Barnes et al., 2015) . Moreover, Tgfbr1 À/À Treg cells also exhibited reduced expression of GPR15 (Figure 5H ), a G-proteincoupled receptor important in colonic T cell trafficking (Kim et al., 2013) . Increased expression of GPR174 and decreased expression of GPR15 were also seen on Tgfbr1 À/À Treg cells post in vitro activation ( Figure S5J ). Collectively, these data demonstrate that, in the absence of TGF-b signals, Treg cells not only have a reduced ability to accumulate in the colon, but also that those Treg cells present in the colon exhibit an elevated sensitivity to local LysoPS, shown to limit their capacity to be sustained in the GI environment (Barnes et al., 2015 were examined, data presented relative to control. Bar graphs show data from three separate experiments combined. ***p < 0.0001, **p < 0.001 were determined by unpaired two-tailed Student's t test, unless otherwise indicated. Error bars represent mean ± SEM. See also Figure S5 .
Most canonical Treg cell factors and signaling intermediates
DISCUSSION
That TGF-b signals limit autoimmunity and aberrant inflammation is well-established (Konkel and Chen, 2011) . Deletion of TGF-b receptors on T cells drives a severe lympho-proliferative disease that results in death of mice within weeks of birth (Li et al., 2006; Liu et al., 2008; Marie et al., 2006) . TGF-b provides vital signals that limit immune activation, and enhanced mortality is seen in mice lacking TGF-b-receptor expression not only on T cells but also on Dendritic cells, B cells, and myeloid cells (Cazac and Roes, 2000; Novitskiy et al., 2012; Ramalingam et al., 2012) . Given the vital role TGF-b plays in driving Treg cell generation (Konkel et al., 2014; Liu et al., 2008) , that we show no severe inflammatory dysfunction in mice lacking TGF-bRI expression specifically on Treg cells is perhaps somewhat surprising. Previous reports suggested that TGF-b was required for Treg cell maintenance (Marie et al., 2005) ; however, our data indicate that in the absence of TGF-b signals, Foxp3 + cells are maintained, survive, and are able to control certain inflammatory responses. Our data demonstrate that Tgfbr1 À/À Treg cells are functional and that these cells exhibit enhanced suppressive capabilities against IFN-g production. We show that Tgfbr1 À/À Treg cells express enhanced T-bet, and this directly contributes to their elevated ability to suppress IFN-g production by CD4 + T cells. (Lochner et al., 2008; Tartar et al., 2010; Yang et al., 2015) , and it is possible that reduced expression of RORgt in Treg cells could account for impaired Th17 suppression by Tgfbr1 À/À Treg cells (Sefik et al., 2015) . Finally, in terms of Tgfbr1 À/À Treg cells being able to increase IL-17 production by CD4 + T cells in the presence of IL-6, we have shown that Tgfbr1 À/À Treg cells did not exhibit elevated TGF-b or CD25 expression-two factors suggested to support Treg cell-aided Th17 differentiation Gutcher et al., 2011 (Barnes et al., 2015) and reduced expression of colon-specific trafficking molecule GPR15 (Kim et al., 2013) . We saw no differences in apoptosis or expression of canonical Treg cell markers. Instead, our data indicate that in the absence of TGF-b-signals, Treg cells differentially respond to colonic environmental cues. In particular, we show that TGF-b negatively regulates GPR174 expression, meaning Tgfbr1
TGF-b can inhibit T-bet expression in conventional T cells (Gor
Treg cells exhibit enhanced responsiveness to LysoPS, which negatively impacts Treg cell homeostasis (Barnes et al., 2015) . Genetic studies have associated elevated GPR174 expression with increased susceptibility to autoimmune diseases (Chu et al., 2013 (Ishigame et al., 2013) . Given these findings, it will now be important to ascertain the TGF-b signaling intermediates that adapt colonic Treg cells to this TGF-b rich environment . Given the report that Smad2 or 3 deficient Treg cells are functional in this setting yet Tak1-deficient Treg cells are not (Gu et al., 2012) , non-canonical TGF-b signals may adapt Treg cells to the colon. The skin is also TGF-b rich, and it has been shown that direct interaction of T cells with keratinocytes drives CD103 expression in a TGF-b-dependent manner (Watanabe et al., 2015) . As expression of CD103 by Treg cells in the skin is required for their localization (Suffia et al., 2005) 
Flow Cytometry
Single-cell preparations were stained with antibodies from eBioscience, BD, and Biolegend. For antibody details, see Supplemental Experimental Procedures. Ki67 staining was done using a Ki67 kit according to the manufacturer's instructions (BD). Foxp3 expression was examined using the eBioscience Foxp3 Treg kit. Dead cells were excluded using a Live-dead fixable dye (Invitrogen). Samples were analyzed using a Fortessa flow cytometer (BD Biosciences) and using FlowJo software (Tree Star).
Isolation of Immune Cells from Tissues
Cells from the colonic Lamina propria were prepared as previously described (Sun et al., 2007) . Briefly, intra-epithelial lymphocytes were removed and then colons digested with Liberase TL (Roche) and DNase (GIBCO). For preparation of cells from skin, back skin was cleared of fat tissue prior to incubation with Liberase DH (Roche). Cell suspensions were then shredded through 70-mm and 40-mm cell strainers.
In Vitro Treg Assays
For assessment of Treg cell suppression, GFP + Foxp3 + Treg cells were flow cytometrically sorted from control or Tgfbr1 f/f Foxp3-cre + mice and cultured at decreasing ratios with flow cytometry sorted, congenic, CFSE-labeled CD4 + effector cells, T cell depleted irradiated spleen cells, and 0.5 mg/mL anti-CD3. CFSE-dilution of effector T cells was examined by flow cytometry. In some cultures, the following polarizing cytokines were also added, after which effector T cell production of cytokine was examined by addition of GolgiPlug to the cultures for 4 hr and subsequent intracellular cytokine staining: Th1 (IFN-g at 10 ng/mL and IL-12 at 10 ng/mL), Th17 (IL-6 at 50 ng/mL and IL-23 at 10 ng/mL), and Th2 (IL-4 at 10 ng/mL). See Supplemental Experimental Procedures for more details.
Retroviral Constructs and Transduction of Regulatory T Cells
The construct pMIG-DN-T-bet-GFP encoding dominant-negative mouse T-bet (Pearce et al., 2003) was obtained from Jinfang Zhu's laboratory (National Institute of Allergy and Infectious Diseases, National Institutes of Health). cDNA encoding DN-T-bet was subcloned into the pMSCV-IRESCherry retroviral vector. Hek293T cells were transfected with pCL-Eco packaging plasmid and either pMSCV-DN-T-bet-Cherry or the empty pMSCV-IRES-Cherry vector using Turbofect (Thermofisher). Retroviral supernatant was harvested 24-48 hr after transfection. Purified Treg cells (1.5 3 10 6 /well) from Tgfbr1 f/f Foxp3-cre + mice were activated overnight with 1 mg/mL anti-CD3 and 1 mg/mL anti-CD28 in the presence of 10ng/mL IL-2. Cells were then spinfected with viral supernatant and 5ug/mL polybrene at 2500 rpm for 90 min at 32 C. 48 hr later, cells were harvested, stained with antibodies, and FACS-sorted for GFP and Cherry co-expression before being used in suppression assays.
T Cell Transfer Colitis
Following CD4 + T cell enrichment using MACS-beads (Miltenyi Biotech), naive CD4 + CD45RB hi cells were purified from spleens and peripheral lymph nodes (LNs) of congenic C57BL/6 mice via flow cytometry (FACS Aria II, BD). 
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